iShares Biotechnology ETF (IBB)
ETF · Equity · iShares · Data as of 2026-10-22
Bottom line
IBB is an iShares fund that holds companies in one industry, for 0.44% a year. Over the past year its price rose 34.3%, 20.5 points ahead of the S&P 500. It pays about 0.2% a year, every quarter. Past returns are not a guarantee of future results.
Fund facts
Fee: 0.44% a year
Assets: $10.5B
Holdings: 243
Payouts, past 12 months: 0.16%
Past year
34.29% price · 34.56% with payouts
About the fund
The iShares Biotechnology ETF (IBB) is designed to mirror the investment performance of a specific market index. This index comprises publicly traded stocks from companies operating within the U.S. biotechnology sector.
Related funds
- VanEck Semiconductor ETF (SMH)
- iShares Semiconductor ETF (SOXX)
- VanEck Gold Miners ETF (GDX)
- First Trust Nasdaq Cybersecurity ETF (CIBR)
- iShares Expanded Tech-Software Sector ETF (IGV)
- Global X - U.S. Infrastructure Development ETF (PAVE)
- iShares U.S. Aerospace & Defense ETF (ITA)
- State Street SPDR S&P Biotech ETF (XBI)
一句话结论
IBB 是 iShares 旗下持有单一细分行业公司的基金，年费率 0.44%。过去一年价格上涨 34.3%，领先标普 500 20.5 个百分点。每年派息约 0.2%，按季派发。过往表现并不能保证未来的结果。
UnderTheLight 用直白的语言解释股票——估值、价格区间与资金流向。它只描述数据，不构成任何投资建议。
UnderTheLight explains stocks in plain English — valuation, price zones and money flow as traffic lights, recomputed nightly. It describes data; it is not investment advice and never recommends a trade.